Skip to content

A study on the correlation between serum thyroid hormone levels, metabolic abnormalities, and psychiatric symptoms in patients with schizophrenia

A study on the correlation between serum thyroid hormone levels, metabolic abnormalities, and psychiatric symptoms in patients with schizophrenia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400088190
Enrollment
Unknown
Registered
2024-08-13
Start date
2023-09-25
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

Patient group:nothing

Sponsors

Chongqing Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Research group: 1. Meets the diagnostic criteria for schizophrenia in the International Classification of Diseases, 10th edition (ICD-10), and is treated with antipsychotic drugs for at least 6 months. 2. Age is 18 = and = 60 years old; 3. Able to cooperate with pre enrollment physical examinations, understand and cooperate with scale assessments, venous blood sampling, metabolic index measurements, etc; 4. Voluntarily participate in the project and sign an informed consent form. Healthy control group: 1. Age is 18 = and = 60 years old; 2. Able to cooperate with pre enrollment physical examinations, understand and cooperate with scale assessments, venous blood sampling, metabolic index measurements, etc; 3. Voluntarily participate in the project and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Individuals with unclear consciousness, intellectual disabilities, or significant aphasia; 2. Individuals with organic brain diseases or severe physical illnesses, and those who have undergone major surgeries within 3 months; 3. Acute phase of schizophrenia, severe excitement and restlessness, unable to cooperate with researchers; 4. Individuals with thyroid related diseases; 5. Simultaneously suffering from other serious mental illnesses, including but not limited to depressive episodes with persistent psychiatric symptoms, bipolar disorder, acute stress disorder, and post schizophrenia depression; 6. Patients undergoing drug treatment or research that may affect metabolic parameters and changes in thyroid hormone levels;

Design outcomes

Primary

MeasureTime frame
thyroid-stimulating hormone;

Secondary

MeasureTime frame
triiodothyronine;free triiodothyronine;free thyroxine;thyroxine;

Countries

China

Contacts

Public ContactLiying Ai

Chongqing Mental Health Center

276195732@qq.com+86 187 0236 7165

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026